USUnited StatesHealthtentative
FDA decision on CagriSema (Novo Nordisk, obesity) expected in Q4
Novo's answer to Lilly in the obesity market, a major stock catalyst.
- News
- 3/5
- Markets
- 5/5
- Overall
- 4/5
Shared from the PPN World agenda
Also on Thu, Oct 1
- All dayFRFranceCultureday 4/9Paris Fashion Week, spring-summer 2027 ready-to-wear
- All dayUSUnited StatesSciencetentativeStarship: next test flights (V3), targeting the first orbital flight and a propellant transfer demonstration
- All dayUSUnited StatesGovernmentUS government funding deadline — FY2027 begins
- All dayCNChinaSocietyday 1/7National Day Golden Week
- 09:00LULuxembourgEconomic datatentativeEurozone flash inflation (September)
Know what's coming. Read it the second it lands.
PPN World puts the world's scheduled set pieces — central banks, data, elections, summits — beside every press release from 1,400+ feeds in 190+ countries, live. Filter by country, export to your calendar, get alerted.
Cancel anytime · CA$99/month
Open the agenda in PPN World →About the World Agenda →
Shared via PPN World — real-time press release intelligence.